TURIBOL 10

DESCRIPTION
Turinabol 10 is a 17-alpha alkylated anabolic steroid for oral use. It promotes anabolism
through androgen receptor activity and is strongly anabolic and moderately androgenic.
When taken in clinical doses, it produces potent increases in strength and moderate
increases in muscle mass. In short term clinical trials, it has been well tolerated in healthy
male subjects during 6 weeks of treatment.

INDICATIONS
Turinabol 10 is indicated as alternate or adjunctive therapy in patients for the promotion of
weight gain following weight loss and/or muscular atrophy associated with extensive surgery,
chronic infections, Long term hospitalization, or severe trauma. Turinabol 10 is indicated to
compensate for protein catabolism consequent to corticosteroid therapy.The physician and
patient must consider the risks of therapy versus the potential benefits.

ADVERSE REACTIONS
Male: Gynecomastia, excessive frequency and duration of penile erections, oligospermia.
Skin and Appendages: Hirsutism, male pattern baldness and acne, gynecomastia.
Fluid/electrolyte Disturbances: Retention of sodium, chloride, water, potassium, calcium, and inorganic phosphates.
Gastrointestinal: Nausea, cholestatic jaundice, alterations in liver function tests; rarely, hepatocellular neoplasms, peliosis hepatis, hepatic adenomas, and
cholestatic hepatitis.
Hematologic: Suppression of clotting factors II, V, VII, & X: bleeding in patients on anti- coagulant therapy.
Nervous System: Increased or decreased libido, headache, anxiety, depression, and generalized paresthesia.
Other: Serum lipid changes, hypercalcaemia, hypertension, oedema, priapism, and potentiation of sleep apnea.

CONTRAINDICATIONS
Patients with known hypersensitivity to any ingredients in this product. Patients with known
or suspected carcinomas of the breast, testis, or prostate. Patients with severe heart
disease, liver disease, or kidney disease or with a history of epilepsy. Products containing
androgens should not be used in women as they may cause virilization and fetal harm.
Patients with nephrosis or the nephrotic phase of nephritis, ed Patients with hypercalcemia.
sleM Patients with pre-existing cardiac, renal, and/or hepatic disease.

DOSAGE AND ADMINISTRATION
Adult males: 10-30mg taken orally per day in divided doses for a duration of 4 to 6 weeks.

PRESENTATION
Turinabol 10 mg uncoated tablets: 100 tablets in blister

STORAGE
Store in a cool dry place between 15 – 25°C, Protect from beau light.